Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W J Remme

Showing results (41-50 of 102) with videos related to

Pageof 11
Sort By:
The American Journal of Cardiology|July 1, 1977
Effects of pacing-induced myocardial ischemia on hypoxanthine efflux from the human heartW J Remme, J W de Jong, P D Verduow
European Journal of Nuclear Medicine|January 1, 1984
First-pass left ventricular ejection fraction with 95mAu on a 1/4 in. crystal gamma cameraB Shapiro, M Pillay, P H Cox, et al.
Journal of the American College of Cardiology|April 8, 1999
Drug-induced heart failureJ Feenstra, D E Grobbee, W J Remme, et al.
Journal of Cardiac Failure|March 1, 1995
Long-term vasodilator treatment with flosequinan does not lead to hemodynamic tolerance or neurohormonal activation in severe heart failureG L Bartels, W J Remme, M P Look, et al.
Journal of Cardiovascular Pharmacology|January 1, 1989
Hemodynamic effects of intravenous pimobendan in patients with left ventricular dysfunctionW J Remme, A C Wiesfeld, M P Look, et al.
Cardiovascular Drugs and Therapy|November 24, 1998
Neurohumoral response to carmoxirole, a selective dopamine (D2) receptor agonist, in patients with chronic moderate heart failureM van der Ent, A F van den Heuvel, W J Remme
European Heart Journal|March 1, 1996
Anti-ischaemic efficacy of L-propionylcarnitine--a promising novel metabolic approach to ischaemia?G L Bartels, W J Remme, K J Holwerda, et al.
The Journal of Pharmacology and Experimental Therapeutics|March 1, 1978
Antiarrhythmic, metabolic and hemodynamic effects of Org 6001 (3alpha-amino-5alpha-androstan-2beta-ol-17-one-hydrochloride) after coronary flow reduction in pigsP D Verdouw, H C Schamhardt, W J Remme, et al.
Arzneimittel-Forschung|January 1, 1976
Cardiovascular effects of an antiarrhythmic aminosteroid ORG 6001 in the anesthetized pigP D Verdouw, W J Remme, J Beaune, et al.
Journal of the American College of Cardiology|March 1, 1993
Hemodynamic tolerability and anti-ischemic efficacy of high dose intravenous diltiazem in patients with normal versus impaired ventricular functionW J Remme, X H Krauss, D C van Hoogenhuyze, et al.
Pageof 11

Showing results (41-50 of 102) with videos related to

Sort By:
Pageof 11
The American Journal of Cardiology|July 1, 1977
Effects of pacing-induced myocardial ischemia on hypoxanthine efflux from the human heartW J Remme, J W de Jong, P D Verduow
European Journal of Nuclear Medicine|January 1, 1984
First-pass left ventricular ejection fraction with 95mAu on a 1/4 in. crystal gamma cameraB Shapiro, M Pillay, P H Cox, et al.
Journal of the American College of Cardiology|April 8, 1999
Drug-induced heart failureJ Feenstra, D E Grobbee, W J Remme, et al.
Journal of Cardiac Failure|March 1, 1995
Long-term vasodilator treatment with flosequinan does not lead to hemodynamic tolerance or neurohormonal activation in severe heart failureG L Bartels, W J Remme, M P Look, et al.
Journal of Cardiovascular Pharmacology|January 1, 1989
Hemodynamic effects of intravenous pimobendan in patients with left ventricular dysfunctionW J Remme, A C Wiesfeld, M P Look, et al.
Cardiovascular Drugs and Therapy|November 24, 1998
Neurohumoral response to carmoxirole, a selective dopamine (D2) receptor agonist, in patients with chronic moderate heart failureM van der Ent, A F van den Heuvel, W J Remme
European Heart Journal|March 1, 1996
Anti-ischaemic efficacy of L-propionylcarnitine--a promising novel metabolic approach to ischaemia?G L Bartels, W J Remme, K J Holwerda, et al.
The Journal of Pharmacology and Experimental Therapeutics|March 1, 1978
Antiarrhythmic, metabolic and hemodynamic effects of Org 6001 (3alpha-amino-5alpha-androstan-2beta-ol-17-one-hydrochloride) after coronary flow reduction in pigsP D Verdouw, H C Schamhardt, W J Remme, et al.
Arzneimittel-Forschung|January 1, 1976
Cardiovascular effects of an antiarrhythmic aminosteroid ORG 6001 in the anesthetized pigP D Verdouw, W J Remme, J Beaune, et al.
Journal of the American College of Cardiology|March 1, 1993
Hemodynamic tolerability and anti-ischemic efficacy of high dose intravenous diltiazem in patients with normal versus impaired ventricular functionW J Remme, X H Krauss, D C van Hoogenhuyze, et al.
Pageof 11